These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 20576430

  • 1. Propenylamide and propenylsulfonamide cephalosporins as a novel class of anti-MRSA beta-lactams.
    Pohlmann J, Vasilevich NI, Glushkov AI, Kellenberger L, Shapiro S, Caspers P, Page MG, Danel F.
    Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4635-8. PubMed ID: 20576430
    [Abstract] [Full Text] [Related]

  • 2. Exploring the positional attachment of glycopeptide/beta-lactam heterodimers.
    Long DD, Aggen JB, Chinn J, Choi SK, Christensen BG, Fatheree PR, Green D, Hegde SS, Judice JK, Kaniga K, Krause KM, Leadbetter M, Linsell MS, Marquess DG, Moran EJ, Nodwell MB, Pace JL, Trapp SG, Turner SD.
    J Antibiot (Tokyo); 2008 Oct 01; 61(10):603-14. PubMed ID: 19168974
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus.
    Zhao WH, Hu ZQ, Okubo S, Hara Y, Shimamura T.
    Antimicrob Agents Chemother; 2001 Jun 01; 45(6):1737-42. PubMed ID: 11353619
    [Abstract] [Full Text] [Related]

  • 4. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
    Yoshizawa H, Kubota T, Itani H, Ishitobi H, Miwa H, Nishitani Y.
    Bioorg Med Chem; 2004 Aug 01; 12(15):4211-9. PubMed ID: 15246097
    [Abstract] [Full Text] [Related]

  • 5. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
    Yoshizawa H, Kubota T, Itani H, Minami K, Miwa H, Nishitani Y.
    Bioorg Med Chem; 2004 Aug 01; 12(15):4221-31. PubMed ID: 15246098
    [Abstract] [Full Text] [Related]

  • 6. The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains.
    Hardej D, Ashby CR, Khadtare NS, Kulkarni SS, Singh S, Talele TT.
    Eur J Med Chem; 2010 Dec 01; 45(12):5827-32. PubMed ID: 20947220
    [Abstract] [Full Text] [Related]

  • 7. [Induction of PBP2' by antibiotics and disinfectants in MRSE].
    Hen K, Imafuku Y, Yoshida H.
    Rinsho Byori; 2008 Nov 01; 56(11):955-60. PubMed ID: 19086449
    [Abstract] [Full Text] [Related]

  • 8. 5,6-Cis-penems: broad-spectrum anti-methicillin-resistant Staphylococcus aureus beta-lactam antibiotics.
    Ishiguro M, Tanaka R, Namikawa K, Nasu T, Inoue H, Nakatsuka T, Oyama Y, Imajo S.
    J Med Chem; 1997 Jul 04; 40(14):2126-32. PubMed ID: 9216830
    [Abstract] [Full Text] [Related]

  • 9. Can beta-lactams be re-engineered to beat MRSA?
    Livermore DM.
    Clin Microbiol Infect; 2006 Apr 04; 12 Suppl 2():11-6. PubMed ID: 16524423
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
    Hu L, Kully ML, Boykin DW, Abood N.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4626-9. PubMed ID: 19589676
    [Abstract] [Full Text] [Related]

  • 11. High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
    Cheng TJ, Wu YT, Yang ST, Lo KH, Chen SK, Chen YH, Huang WI, Yuan CH, Guo CW, Huang LY, Chen KT, Shih HW, Cheng YS, Cheng WC, Wong CH.
    Bioorg Med Chem; 2010 Dec 15; 18(24):8512-29. PubMed ID: 21075637
    [Abstract] [Full Text] [Related]

  • 12. A multivalent approach to drug discovery for novel antibiotics.
    Long DD, Aggen JB, Christensen BG, Judice JK, Hegde SS, Kaniga K, Krause KM, Linsell MS, Moran EJ, Pace JL.
    J Antibiot (Tokyo); 2008 Oct 15; 61(10):595-602. PubMed ID: 19168973
    [Abstract] [Full Text] [Related]

  • 13. Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
    Hu L, Kully ML, Boykin DW, Abood N.
    Bioorg Med Chem Lett; 2009 Jul 01; 19(13):3374-7. PubMed ID: 19481935
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and evaluation of novel sulfenamides as novel anti Methicillin-resistant Staphylococcus aureus agents.
    Shang JL, Guo H, Li ZS, Ren B, Li ZM, Dai HQ, Zhang LX, Wang JG.
    Bioorg Med Chem Lett; 2013 Feb 01; 23(3):724-7. PubMed ID: 23265879
    [Abstract] [Full Text] [Related]

  • 15. Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175).
    Miller K, Storey C, Stubbings WJ, Hoyle AM, Hobbs JK, Chopra I.
    J Antimicrob Chemother; 2005 Apr 01; 55(4):579-82. PubMed ID: 15722396
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and antistaphylococcal activity of N-substituted-1H-benzimidazole-sulphonamides.
    Püsküllü MO, Yildiz S, Göker H.
    Arch Pharm (Weinheim); 2010 Jan 01; 343(1):31-9. PubMed ID: 19927309
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and structure-activity relationship of (lactamylvinyl)cephalosporins exhibiting activity against staphylococci, pneumococci, and enterococci.
    Heinze-Krauss I, Angehrn P, Guerry P, Hebeisen P, Hubschwerlen C, Kompis I, Page MG, Richter HG, Runtz V, Stalder H, Weiss U, Wei CC.
    J Med Chem; 1996 Apr 26; 39(9):1864-71. PubMed ID: 8627610
    [Abstract] [Full Text] [Related]

  • 18. Novel cephalosporin derivatives possessing a substituted cinnamoyl moiety at the 7 beta-position. Synthesis, structural characterization and antibacterial activity of 3-acetoxymethyl cephalosporin derivatives.
    López MA, Rodríguez Z, González M, Tolón B, Avila R, González I, Garmendía L, Mamposo T, Carrasco R, Pellón R, Vélez H, Fini A.
    Eur J Med Chem; 2004 Aug 26; 39(8):657-64. PubMed ID: 15276299
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
    Hu L, Kully ML, Boykin DW, Abood N.
    Bioorg Med Chem Lett; 2009 Mar 01; 19(5):1292-5. PubMed ID: 19208475
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and potent antimicrobial activity of some novel 4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides.
    Ozden S, Karataş H, Yildiz S, Göker H.
    Arch Pharm (Weinheim); 2004 Oct 01; 337(10):556-62. PubMed ID: 15476288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.